BioSpace News Archive

Business

The Australian Research Council Centre of Excellence in Synthetic Biology and Twist Bioscience Partner to Foster and Accelerate Synthetic Biology Research in Australia

Twist Bioscience (Nasdaq: TWST) and the Australian Research Council (ARC) Centre of Excellence in Synthetic Biology (CoESB) today announced a partnership that will enable CoESB members and partners to order a wide range of Twist products that facilitate research and development.

September 20, 2022
·
4 min read
BioMidwest

MD Anderson Cancer Center Selects ViewRay to Expand MR-Guided Radiation Therapy Program

ViewRay, Inc. announced that the University of Texas MD Anderson Cancer Center in Houston, Texas purchased a MRIdian® MR-Guided Radiation Therapy System.

September 20, 2022
·
5 min read
Drug Development

Merck to Initiate New Phase 3 Clinical Program with Lower Dose of Daily Oral Islatravir in Combination with Doravirine for Treatment of People with HIV-1 Infection

Merck, known as MSD outside of the United States and Canada, announced that the company will initiate a new Phase 3 clinical program with once-daily islatravir for the treatment of people with HIV-1 infection.

September 20, 2022
·
6 min read
EMA Accepts MediWound’s Application for Extended Indication for NexoBrid to Treat Pediatric Patients with Severe Thermal Burns

MediWound Ltd. today announced that the European Medicines Agency (EMA) has validated for review the Type II Variation submitted by MediWound in order to expand the current approved indication for NexoBrid (removal of eschar in adults with deep partial-and full-thickness thermal burns.

September 20, 2022
·
9 min read
Business

Renalytix Announces Change to Board of Directors

Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that Ann Berman, non-executive director and chair of the audit and nomination committees, has resigned as a director of the Company for personal reasons effective immediately.

September 20, 2022
·
2 min read
Business

LUNGevity Foundation Issues Five Health Equity and Inclusiveness Research Awards

LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, is pleased to announce the recipients of their 2022 Health Equity and Inclusiveness Research Awards.

September 20, 2022
·
6 min read
Drug Development

Synairgen to Present 60 and 90-day Long COVID Data From Phase 3 SPRINTER Study in Hospitalised COVID-19 Patients at IDWeek 2022

Synairgen plc today announces it will present its positive findings from the analysis of data from 60 and 90-day follow-up visits from the Phase 3 SPRINTER trial in patients hospitalised with COVID-19 at IDWeek 2022 to be held 19-23 October 2022 in Washington, D.C.

September 20, 2022
·
5 min read
FDA

Alterity Therapeutics Receives U.S. FDA Approval for Investigational New Drug Application for ATH434 for the Treatment of Multiple System Atrophy

Alterity Therapeutics today announced the approval of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) to allow evaluation of ATH434 in individuals with Multiple System Atrophy (MSA), a rare and highly debilitating Parkinsonian disorder.

September 20, 2022
·
4 min read
Business

Generation Bio Names Phillip Samayoa, Ph.D. Chief Strategy Officer

Generation Bio Co. announced the promotion of Phillip Samayoa, Ph.D., to chief strategy officer.

September 20, 2022
·
4 min read
Biotech Beach

Discount Pricing for POGO Automatic® Blood Glucose Monitoring System Now Offered Through Costco Member Prescription Program

Intuity Medical, Inc. announced that the POGO Automatic® Blood Glucose Monitoring System and POGO Automatic® Test Cartridges are now available with discount pricing through the Costco Member Prescription Program.

September 20, 2022
·
3 min read